Stock Ticker

  • Loading stock data...

Lifevantage Receives a Battlefield Promotion (LFVN)

Beginning on September 12, 2012, shares of Lifevantage (OTC: LFVN) will commence trading on the NASDAQ under the same symbol that the stock carries now. Companies eligible for listing on the NASDAQ must meet specific criteria regarding their financials and market capitalization. Douglas Robison, President and CEO of Lifevantage, said the following, “Over the past […]

Positive News for Advanced Cell Technology, 2nd Quarter Results Out and Chairman to Present at Prestigious Conference (ACTC)

Massachusetts-based biotechnology company, Advanced Cell Technology (ACTC), has quite a few things going for it this quarter. The biotechnology company is primarily into the application of cellular technology to solve problems in the field of regenerative medicine. Not only is this penny stock company one of the most actively traded over the counter stock, but […]

Nanoviricides Punches the Competition in the Mouth (NNVC)

Nanoviricides (OTC: NNVC) reported today that its oral anti-influenza drug, FluCide, showed superior results to oral Tamiflu. Produced by Roche, Tamiflu has become the standard treatment for influenza. According to Nanoviricides, its drug beat Tamiflu in every parameter tested. The tests, however, were conducted on mice. The market for a successful influenza drug can be quite […]

Dividend and Conquer, Medisafe 1 Technologies Doubles (MFTH)

WallSteetPR has covered Medisafe 1 Technologies (OTC: MFTH) before today. Looking at today’s numbers, it is quite clear that people remain afraid of needles. People also fear being accidentally administered drugs intended for another patient, an incorrect dosage, or simple incompetence as well of a host of other problems that hospitals fight each time a patient […]

Protocol Completion For Tropine 3 Clinical Trial Ensures Rally In Pristine Solutions (PRTN)

Following the news of an agreement with Rox San Pharmacy and completion of Protocol for the Clinical Trial for Tropine 3, the shares of Pristine Solutions (OTC: PRTN) continued the upward journey with a 76% gain from an intra-day low of $0.17 on September 4, 2012. Pristine Solutions came into the lime light nearly two […]

Three-Dimensional Bioprinter’s Potential Revives Interest In Organovo Holdings (ONVO)

The developer of the NovoGen MMX Bioprinter, Organovo Holdings (OTC: ONVO), continued to attract traders following an “outperform” rating a week ago from Zacks Small Cap Research. In yesterday’s trading session, the share price rose by $0.07 to $2.23 in the first hour of trading and resisted short sellers for the rest of the day. […]

Transgenomic Ices Cancer Kicker (TBIO)

Transgenomic (OTC: TBIO) announced this morning that it had a collaborative arrangement with New York University’s Langone Medical Center to use the company’s ultra-high sensitive mutation detection technology, known as ICE COLD-PCR, to study lung cancer and responses to a variety of treatments. The focus of the study centers on mutations found in the blood of […]

Traders Look Towards Psoriasis Trials To Clear Investment Complexion (CTIX)

Before the market opened this morning after the Labor Day weekend, Cellceutix (OTC: CTIX) announced that it had selected Dr. Reddy’s Laboratory (NYSE: RDY) to manufacture the drug Purisol for the treatment of psoriasis. Cellceutix plans to commence phase two and three clinical trials upon completion of the manufacturing process. In tests involving mice, Purisol demonstrated […]

LifeVantage Handles CFO Transition Deftly While Facebook’s Stock Continues to Suffer (LFVN) (FB)

David Ebersman, Chief Financial Officer of Facebook (NASDAQ: FB), is being touted as the man behind the flawed Facebook IPO that took the market by storm three months ago. While the blame game is being played in the Facebook IPO debacle, penny stock companies like LifeVantage (OTCQB: LFVN) are handling CFO changes without any controversy. […]

InVivo Therapeutics Staggers over Recent Positive News (NVIV)

Two weeks ago, InVivo Therapeutics (OTC: NVIV) released second quarter financial results that showed a pro forma loss of $0.04 versus a loss $0.05 for the same period last year. The company also mentioned the clinical progress for its biopolymer scaffolding and hydrogel technologies. According to the report, the FDA is prepared to clear the […]

It’s One Thing to Hate Needles, Another to Hate the Needle Filled with the Medicine Prescribed to the Patient in the Next Room (MFTH)

You are certainly not alone if you struggle with watching (hopefully) a medical practitioner readying a needle for the introduction of clear liquid into your IV, or even directly in to your vein. Equally, or perhaps even more frightening, is that there exist many occasions when you will not be in possession of the faculties […]

Americans Like Their Caffeine, Taurine and High Fructose Corn Syrups (CUBV)

Cuba Beverage Company (OTC: CUBV) took a beating in today’s trading, dropping nearly 60% of its value after a horrendous opening. Cuba Beverage began the day at $0.096 before dropping sharply in the first hour of trading to $0.05. The stock never rebounded, but dipped even further, closing the day at $0.04 on a trading […]

This is The Dawning of The Age of (Turnkey) Aquarius (HAIR)

Surprisingly, this dawning meant a drop of over 11% for Biostem U.S. (OTC: HAIR) earlier today. Biostem U.S. is a Nevada corporation with offices in Clearwater, Florida, that intends to help men and women overcome unwanted baldness. The company intends to facilitate this cure by helping stimulate hair growth through the use of platelet-rich plasma […]

Sign Up To Get Our Latest Stocks Alerts